Marka sorgulama · Bülten 492

immunitybio

NANTCELL, INC.

Yayımlandı, itiraz süresi doldu Başvuru no 2026/046258 · 10 Mart 2026 · vekilsiz başvuru

Süreç

  1. Başvuru 10 Mart 2026
  2. Bültende yayın Resmî Marka Bülteni 492 · 12 Mayıs 2026
  3. İtiraz penceresi (2 ay) Son gün 12 Temmuz 2026 · kapandı
  4. Tescil Bekleniyor — itiraz gelmezse ilan sonrası inceleme ve tescil harcı aşamasına geçer.

Resmî süreler ve işlemler için TÜRKPATENT esastır; Nomist bilgilendirme aracıdır.

Bu marka senin mi? Benzer bir başvuru bültene düştüğü gün e-posta alırsın; ilk marka ücretsiz. Web'de ya da uygulamada.

Sınıflar ve kapsam

Mal ve hizmet listesi

Pharmaceutical preparations and substances for the treatment of human diseases, animal diseases, autoimmune diseases, infectious diseases and cancer for scientific, clinical, medicinal, therapeutic, and diagnostic purposes; pharmaceutical preparations and substances for the prevention, diagnosis, and treatment of human diseases, animal diseases, autoimmune diseases, infectious diseases and cancer; pharmaceutical and biological preparations for use in targeted immunotherapy for the treatment of human diseases, animal diseases, autoimmune diseases, infectious diseases and cancer; biological preparations for medical purposes, namely, in the field of vaccines; pharmaceutical preparations for low-dose chemotherapies, low dose radiation therapies, and personalized neoepitope-targeted therapies for medical use for the treatment of human diseases, animal diseases, autoimmune diseases, infectious diseases, and cancer; anti-cancer preparations; vaccines; biologics, namely, cell-derived preparations, pharmaceutical preparations for cell therapies, monoclonal antibodies, cytokines, immune modulators, pharmaceutical preparations for low-dose chemotherapy and low-dose radiation therapy, antibodies, fusion proteins, peptide and cytokine biologics, vaccines, pharmaceutical preparations for personalized neoepitope- based therapies and cell therapies, and natural killer cell derived preparations for clinical, medicinal, therapeutic, and veterinary purposes; kits for clinical, medicinal, therapeutic, and veterinary purposes featuring cell cultures, and reagents.Medical and pharmaceutical research and development services; medical and scientific research in the fields of pharmaceuticals, oncology, immune -oncology, immunotherapy, human diseases, animal diseases, cancer, vaccines, autoimmune diseases, and infectious diseases; product development in the fields of pharmaceuticals, oncology, immune- oncology, immunotherapy, human diseases, animal diseases, cancer, vaccines, autoimmune diseases, and infectious diseases.Medical services; medical information; providing medical information in the fields of immunotherapy via a website; providing medical information in the fields of human diseases, animal diseases, cancer, vaccines, autoimmune diseases, and infectious diseases via a website; providing information relating to pharmaceuticals, oncology, immune -oncology, immunotherapy, human diseases, animal diseases, cancer, vaccines, autoimmune diseases, infectious diseases, biologics, cells, and cell-derived preparations.

Aynı bültende benzer başvurular

Bülten 492 içindeki 1.262 aynı-sınıf başvuru tarandı; 2 benzer bulundu.

  • ı••• Yüksek benzerlik 5 31 35
  • g••• Orta benzerlik 9 35 36 41 42

İsimler uygulamada, Nomist Pro ile görünür.